Importance:
Quality metrics for patients with head and neck cancer are available, but it is unknown whether compliance with these metrics is associated with improved patient survival.
Objective:
To identify whether compliance with various process-related quality metrics is associated with improved survival in patients with oral cavity squamous cell carcinoma who receive definitive surgery with or without adjuvant therapy.
Design, Setting, And Participants:
A retrospective cohort study was conducted at a tertiary academic medical center among 192 patients with previously untreated oral cavity squamous cell carcinoma who underwent definitive surgery with or without adjuvant therapy between January 1, 2003, and December 31, 2010. Data analysis was performed from January 26 to August 7, 2015.
Interventions:
Surgery with or without adjuvant therapy.
Main Outcomes And Measures:
Compliance with a collection of process-related quality metrics possessing face validity that covered pretreatment evaluation, treatment, and posttreatment surveillance was evaluated. Association between compliance with these quality metrics and overall survival, disease-specific survival, and disease-free survival was calculated using univariable and multivariable Cox proportional hazards analysis.
Results:
Among 192 patients, compliance with the individual quality metrics ranged from 19.7% to 93.6% (median, 82.8%). No pretreatment or surveillance metrics were associated with improved survival. Compliance with the following treatment-related quality metrics was associated with improved survival: elective neck dissection with lymph node yield of 18 or more, no unplanned surgery within 14 days of the index surgery, no unplanned 30-day readmissions, and referral for adjuvant radiotherapy for pathologic stage III or IV disease. Increased compliance with a "clinical care signature" composed of these 4 metrics was associated with improved overall survival, disease-specific survival, and disease-free survival on univariable analysis (log-rank test; P < .05 for each). On multivariable analysis controlling for pT stage, pN stage, extracapsular spread, margin status, and comorbidity, increased compliance with these 4 metrics was associated with improved overall survival (100% vs ≤50% compliance: adjusted hazard ratio [aHR], 4.2; 95% CI, 2.1-8.5; 100% vs 51%-99% compliance: aHR, 1.7; 95% CI, 1.0-3.1), improved disease-specific survival (100% vs ≤50% compliance: aHR, 3.9; 95% CI, 1.7-9.0; 100% vs 51%-99%: aHR, 1.3; 95% CI, 0.6-2.9), and improved disease-free survival (100% vs ≤50% compliance: aHR, 3.0; 95% CI, 1.5-5.8; 100% vs 51%-99% compliance: aHR, 1.6; 95% CI, 0.9-2.7).
Conclusions And Relevance:
Compliance with a core set of process-related quality metrics was associated with improved survival for patients with surgically managed oral cavity squamous cell carcinoma. Multi-institutional validation of these metrics is warranted.
Citing Articles
Time-to-Treatment Delays and Their Prognostic Implications in Pharyngeal Cancer-An Exploratory Analysis in Western Romania.
Kis A, Buzatu R, Chisavu L, Poenaru M, Borza C, Iftode A
Clin Pract. 2024; 14(4):1270-1284.
PMID: 39051297
PMC: 11270176.
DOI: 10.3390/clinpract14040103.
Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis.
Duckett K, Kassir M, Nguyen S, Brennan E, Chera B, Sterba K
Otolaryngol Head Neck Surg. 2024; 171(5):1265-1282.
PMID: 38842034
PMC: 11499046.
DOI: 10.1002/ohn.835.
Opportunistic pathogen targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors.
Sheridan M, Chowdhury N, Wellslager B, Oleinik N, Kassir M, Lee H
iScience. 2024; 27(6):109860.
PMID: 38779482
PMC: 11108982.
DOI: 10.1016/j.isci.2024.109860.
Eugene Nicholas Myers' Lecture on Head and Neck Cancer, 2020: The Surgeon as a Prognostic Factor in Head and Neck Cancer Patients Undergoing Surgery.
Kowalski L
Int Arch Otorhinolaryngol. 2023; 27(3):e536-e546.
PMID: 37564472
PMC: 10411134.
DOI: 10.1055/s-0043-1761170.
Feasibility, Safety, Nodal yields and Learning curves in Retroauricular Robot/Endoscope Assisted Neck Dissection in the Management of Head and Neck Cancer.
Kathar M, Jain P, Manikantan K, Arun P, Koh Y, Sharan R
Indian J Surg Oncol. 2022; 12(4):808-815.
PMID: 35110907
PMC: 8763986.
DOI: 10.1007/s13193-021-01444-z.
Head and neck cancers: Monitoring quality and reporting outcomes.
Chilkuri M, Vangaveti V, Smith J
J Med Imaging Radiat Oncol. 2021; 66(3):455-465.
PMID: 34851013
PMC: 9299932.
DOI: 10.1111/1754-9485.13359.
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.
Graboyes E, Sterba K, Li H, Warren G, Alberg A, Calhoun E
JCO Oncol Pract. 2021; 17(10):e1512-e1523.
PMID: 33689399
PMC: 8791819.
DOI: 10.1200/OP.20.00943.
The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y, Liu M, Yao J, Guo Q, Wei L
Molecules. 2020; 25(21).
PMID: 33143000
PMC: 7663336.
DOI: 10.3390/molecules25215033.
The Efficacy of Low Postoperative Radiation Dose in Patients with Advanced Hypopharyngeal Cancer without High-Risk Factors.
Tao H, Shen Z, Liu Z, Wei Y
Cancer Manag Res. 2020; 12:7553-7560.
PMID: 32943918
PMC: 7468485.
DOI: 10.2147/CMAR.S249725.
Framework for prioritizing head and neck surgery during the COVID-19 pandemic.
Topf M, Shenson J, Holsinger F, Wald S, Cianfichi L, Rosenthal E
Head Neck. 2020; 42(6):1159-1167.
PMID: 32298036
PMC: 7262168.
DOI: 10.1002/hed.26184.
Best Practice in Surgical Treatment of Malignant Head and Neck Tumors.
Simon C, Nicolai P, Paderno A, Dietz A
Front Oncol. 2020; 10:140.
PMID: 32117778
PMC: 7028740.
DOI: 10.3389/fonc.2020.00140.
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review.
Graboyes E, Kompelli A, Neskey D, Brennan E, Nguyen S, Sterba K
JAMA Otolaryngol Head Neck Surg. 2018; 145(2):166-177.
PMID: 30383146
PMC: 6494704.
DOI: 10.1001/jamaoto.2018.2716.
Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma.
Janz T, Kim J, Hill E, Sterba K, Warren G, Sharma A
JAMA Otolaryngol Head Neck Surg. 2018; 144(12):1105-1114.
PMID: 30347012
PMC: 6472989.
DOI: 10.1001/jamaoto.2018.2225.
Treatment Patterns in Veterans with Laryngeal and Oropharyngeal Cancer and Impact on Survival.
Richardson P, Kansara S, Chen G, Sabichi A, Sikora A, Parke R
Laryngoscope Investig Otolaryngol. 2018; 3(4):275-282.
PMID: 30186958
PMC: 6119785.
DOI: 10.1002/lio2.170.
Performance Improvement in Head and Neck Cancer.
Lewis C, Weber R
Curr Oncol Rep. 2018; 20(1):1.
PMID: 29349566
DOI: 10.1007/s11912-018-0655-4.
Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data: Negative Margin Rates and Neck Dissection Yield.
Schoppy D, Rhoads K, Ma Y, Chen M, Nussenbaum B, Orosco R
JAMA Otolaryngol Head Neck Surg. 2017; 143(11):1111-1116.
PMID: 28983555
PMC: 5710350.
DOI: 10.1001/jamaoto.2017.1694.
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes E, Garrett-Mayer E, Ellis M, Sharma A, Wahlquist A, Lentsch E
Cancer. 2017; 123(24):4841-4850.
PMID: 28841234
PMC: 5759768.
DOI: 10.1002/cncr.30939.
Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes E, Townsend M, Kallogjeri D, Piccirillo J, Nussenbaum B
JAMA Otolaryngol Head Neck Surg. 2016; 142(12):1154-1163.
PMID: 27435696
PMC: 6086577.
DOI: 10.1001/jamaoto.2016.0657.